Stifel Financial Corp Teva Pharmaceutical Industries LTD Transaction History

Stifel Financial Corp

  • $86.8 Billion
  • Q2 2024

A detailed history of Stifel Financial Corp transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Stifel Financial Corp holds 43,108 shares of TEVA stock, worth $770,339. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,108
Previous 38,245 12.72%
Holding current value
$770,339
Previous $539,000 29.87%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$12.78 - $17.4 $62,149 - $84,616
4,863 Added 12.72%
43,108 $700,000
Q1 2024

May 13, 2024
BUY
$10.67 - $14.43 $36,139 - $48,874
3,387 Added 9.72%
38,245 $539,000
Q4 2023

Feb 12, 2024
SELL
$8.12 - $10.63 $30,912 - $40,468
-3,807 Reduced 9.85%
34,858 $363,000
Q3 2023

Nov 13, 2023
SELL
$7.48 - $10.7 $102,505 - $146,632
-13,704 Reduced 26.17%
38,665 $394,000
Q2 2023

Aug 14, 2023
BUY
$7.2 - $9.47 $40,212 - $52,889
5,585 Added 11.94%
52,369 $394,000
Q1 2023

May 12, 2023
BUY
$8.36 - $11.37 $32,746 - $44,536
3,917 Added 9.14%
46,784 $414,000
Q4 2022

Feb 13, 2023
BUY
$7.95 - $9.48 $97,959 - $116,812
12,322 Added 40.34%
42,867 $390,000
Q3 2022

Nov 14, 2022
BUY
$6.86 - $11.95 $1,872 - $3,262
273 Added 0.9%
30,545 $247,000
Q2 2022

Aug 15, 2022
BUY
$7.38 - $10.4 $1,099 - $1,549
149 Added 0.49%
30,272 $227,000
Q1 2022

May 13, 2022
SELL
$7.33 - $9.39 $51,881 - $66,462
-7,078 Reduced 19.03%
30,123 $283,000
Q4 2021

Feb 14, 2022
BUY
$7.9 - $10.19 $33,101 - $42,696
4,190 Added 12.69%
37,201 $298,000
Q3 2021

Nov 15, 2021
SELL
$8.38 - $10.18 $23,891 - $29,023
-2,851 Reduced 7.95%
33,011 $321,000
Q2 2021

Aug 13, 2021
SELL
$9.9 - $11.56 $20,037 - $23,397
-2,024 Reduced 5.34%
35,862 $355,000
Q1 2021

May 14, 2021
SELL
$10.34 - $12.81 $69,029 - $85,519
-6,676 Reduced 14.98%
37,886 $437,000
Q4 2020

Feb 12, 2021
SELL
$8.61 - $11.04 $47,277 - $60,620
-5,491 Reduced 10.97%
44,562 $430,000
Q3 2020

Nov 16, 2020
BUY
$8.57 - $12.69 $40,090 - $59,363
4,678 Added 10.31%
50,053 $452,000
Q2 2020

Aug 14, 2020
SELL
$8.12 - $13.12 $70,554 - $113,999
-8,689 Reduced 16.07%
45,375 $560,000
Q1 2020

May 14, 2020
BUY
$6.69 - $13.45 $60,330 - $121,292
9,018 Added 20.02%
54,064 $488,000
Q4 2019

Feb 13, 2020
SELL
$6.53 - $10.72 $312,277 - $512,651
-47,822 Reduced 51.49%
45,046 $444,000
Q3 2019

Nov 19, 2019
BUY
$6.16 - $9.6 $1,848 - $2,880
300 Added 0.32%
92,868 $635,000
Q3 2019

Nov 13, 2019
BUY
$6.16 - $9.6 $168,543 - $262,665
27,361 Added 41.96%
92,568 $633,000
Q2 2019

Aug 14, 2019
SELL
$8.12 - $15.72 $2.46 Million - $4.77 Million
-303,215 Reduced 82.3%
65,207 $607,000
Q1 2019

May 14, 2019
SELL
$15.58 - $20.01 $14,987 - $19,249
-962 Reduced 0.26%
368,422 $5.77 Million
Q4 2018

Feb 13, 2019
SELL
$14.59 - $23.84 $156,915 - $256,399
-10,755 Reduced 2.83%
369,384 $5.68 Million
Q3 2018

Nov 13, 2018
BUY
$21.06 - $25.65 $204,176 - $248,676
9,695 Added 2.62%
380,139 $8.18 Million
Q2 2018

Aug 14, 2018
BUY
$16.77 - $24.71 $65,771 - $96,912
3,922 Added 1.07%
370,444 $9 Million
Q1 2018

May 11, 2018
SELL
$16.68 - $22.07 $1.08 Million - $1.43 Million
-64,836 Reduced 15.03%
366,522 $6.26 Million
Q4 2017

Feb 14, 2018
SELL
$11.23 - $19.1 $1.53 Million - $2.61 Million
-136,654 Reduced 24.06%
431,358 $8.19 Million
Q3 2017

Nov 13, 2017
BUY
$15.41 - $32.17 $8.75 Million - $18.3 Million
568,012
568,012 $0

Others Institutions Holding TEVA

# of Institutions
603
Shares Held
567M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Stifel Financial Corp Portfolio

Follow Stifel Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Stifel Financial Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email